System integrates artificial intelligence to maximize conventional and spectral CT capabilities.
Canon Medical Systems received 510(k) clearance from the U.S. Food and Drug Administration on Wednesday for the Aquilion ONE/PRISM Edition.
This system, designed for deep intelligence, integrates artificial intelligence technology to maximize conventional and spectral CT automated workflow capabilities, as well as provide clinic insights to support patient-care decision-making.
The Aquilion ONE/PRISM Edition uses the Advanced Intelligent Clear-IQ Engine (AiCE) for CT reconstruction. The product, which is trained on a significant amount of high-quality image data, employs deep learning to differentiate between true signal and noise to deliver clear images quickly.
“Canon Medical’s DLR technology is pushing routine diagnostic imaging into the age of AI assisted imaging, revolutionizing patient care by enabling excellent diagnostic confidence,” said Erin Angel, managing director of Canon Medical’s CT Business Unit. “With Deep Learning Spectral, Canon Medical is able to provide clinicians with a spectral CT system designed to address the trade-offs of traditional spectral CT and, potentially, expand the utilization to more routine CT imaging.”
AiCE can be applied, according to the company statement, to enhance the anatomical resolution for the whole body, including brain, lung, cardiac, and musculoskeletal applications. And, Aquilion ONE/PRISM Edition supports more confident diagnoses with rapid kV switching with patient-specific mA modulation, full field-of-view acquisition, and 16cm coverage. The end-to-end workflow can be integrated into routine protocols, company officials said.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.